Latigo Biotherapeutics Inc. (LTGO) Financials
LTGO Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 64.8 million | 340.8 million |
| March 31, 2026 | 50.6 million | 303.2 million |
| June 30, 2025 | ? | ? |
| March 31, 2025 | ? | ? |
LTGO Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -21.4 million | 2.1 million |
| March 31, 2026 | -27.1 million | 2.0 million |
| June 30, 2025 | -21.6 million | 1.7 million |
| March 31, 2025 | -21.3 million | 1.5 million |
LTGO Net Income
No data available :(
LTGO Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | - | - | 1.4 million |
| March 31, 2026 | - | - | 554000 |
| June 30, 2025 | - | - | - |
| March 31, 2025 | - | - | - |
LTGO Shares Outstanding
LTGO Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | - | 21.2 million | 4.6 million | - |
| March 31, 2026 | - | 17.6 million | 5.8 million | - |
| June 30, 2025 | 33000 | 22.9 million | 2.8 million | - |
| March 31, 2025 | 102000 | 18.7 million | 2.8 million | - |
LTGO Cost of Revenue
No data available :(
LTGO
Price: $14.19
52 week price:
Earnings Per Share: -1.85 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 956.4 million